Literature DB >> 12752682

A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles.

Lynn Slobbe1, Natalie Medlicott, Euan Lockhart, Nigel Davies, Ian Tucker, Majid Razzak, Glenn Buchan.   

Abstract

A single dose vaccine formulation which induces both humoral and cell-mediated immune responses over a prolonged period would provide a potent weapon against infectious disease. We have used a water-in-oil-in-oil, solvent evaporation method for generating poly epsilon-caprolactone microparticles and tested their ability to induce an immune response against the model antigen ovalbumin. We hypothesized that the initial release of antigen from the surface of the poly epsilon-caprolactone microparticles would act as the priming dose and that the delayed release over the following months, due to diffusion from or break-down of the microparticles, would act as a boost to the immune response. Ovalbumin encapsulated in the poly epsilon-caprolactone microparticles was able to induce both antibody and cell-mediated immune responses. However our results suggest that the spontaneous release had little effect on the immune response. Despite this the response was maintained for at least 8 months following a single immunization. Both humoral and cell-mediated immune responses were induced in mice. This simple method of vaccine formulation offers a cost-efficient way to deliver antigen in a single dose to the immune system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752682     DOI: 10.1046/j.1440-1711.2003.01155.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  2 in total

Review 1.  Germinal center enhancement by extended antigen availability.

Authors:  Kimberly M Cirelli; Shane Crotty
Journal:  Curr Opin Immunol       Date:  2017-07-21       Impact factor: 7.486

2.  The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.

Authors:  Emad I Wafa; Sean M Geary; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  Acta Biomater       Date:  2017-01-04       Impact factor: 8.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.